HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

L-Prolinamide, N-methyl-D-phenylalanyl-N-((1S)-4-((aminoiminomethyl)amino)-1-formylbutyl)-, sulfate (1:1)

HCID 60781
New noteNew reactionRequest quotes
Print preview
Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
126721-07-1
Standard SMILES
CN[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C=O)CCCN=C(N)N.O=S(=O)(O)O
InChIKey
BISKEOIROPAOGY-RXQQAGQTSA-N
Molecular formula
C21H34N6O7S
Average molar mass
514.6 g/mol
Monoisotopic mass
514.22096862

Names & identifiers

Preferred name
L-Prolinamide, N-methyl-D-phenylalanyl-N-((1S)-4-((aminoiminomethyl)amino)-1-formylbutyl)-, sulfate (1:1)
IUPAC
(2S)-N-[(2S)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide;sulfuric acid
English name
Methyl-D-Phe-L-Pro-[(S)-4-guanidino-1-formylbutyl]NH2·sulfuric acid
Molecular formula
C21H34N6O7S
Molecular weight
514.6

Names & synonyms

EFEGATRAN SULFATE126721-07-1LY294468 sulfateEfegatran sulphateVB4VCH77JVLY-294468 SULFATEDTXSID10155277RefChem:924433DTXCID6077768L-Prolinamide, N-methyl-D-phenylalanyl-N-((1S)-4-((aminoiminomethyl)amino)-1-formylbutyl)-, sulfate (1:1)Efegatran sulfate [USAN]N-Methyl-D-phenylalanyl-N-((1S)-1-formyl-4-guanidinobutyl)-L-prolinamide sulfate (1:1)
Show more names
GYKI-14766Methyl-D-Phe-L-Pro-[(S)-4-guanidino-1-formylbutyl]NH2·sulfuric acid
Efegatran sulfate (USAN)(2S)-N-[(2S)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide;sulfuric acidL-Prolinamide, N-methyl-D-phenylalanyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-, (S)-, sulfate (1:1)LY 294468 sulfateUNII-VB4VCH77JVEfegatran (sulfate)SCHEMBL564291D-MePhe-Pro-Arg-H.H2SO4

Database identifiers

Properties

Computed structural properties

Topological polar surface area
226 Ų
Hydrogen bond donors
6
Hydrogen bond acceptors
9
Rotatable bonds
11
Heavy atoms
35
Formal charge
0
Complexity
683

Physicochemical properties

FDA UNII
4 VCH77JV · VB4VCH77JV
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
280 · P280-P305+P351+P338

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P280-P305+P351+P338

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Agents that prevent BLOOD CLOTTING.

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

Applications

UsesAntithrombotic.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
CAS
126721-07-1
PubChem CID
60781
DTXSID
DTXSID10155277
ChEMBL
CHEMBL324954
UNII
VB4VCH77JV